SCHEDULE: Newtyn Management Discloses Stake in QuidelOrtho

Newtyn Management, LLC and its affiliate Newtyn TE Partners, LP have filed an amended Schedule 13G, reporting a combined beneficial ownership of 7.8% of QuidelOrtho Corporation's common stock.

Summary

• Newtyn Management, LLC and Newtyn TE Partners, LP have filed an amendment to their Schedule 13G filing.
• As of April 29, 2026, Newtyn TE Partners, LP holds 3,418,500 shares, representing 5.0% of QuidelOrtho Corporation's common stock.
• Newtyn Management, LLC, as the investment manager for Newtyn TE Partners, LP and Newtyn Partners, LP, may be deemed to beneficially own the aggregate shares held by these entities.
• The total beneficial ownership reported by Newtyn Management, LLC is 5,300,000 shares, which equates to 7.8% of the outstanding common stock.
• The total number of outstanding shares of common stock as of February 11, 2026, was approximately 68,081,767, based on the company's Form 10-K filed on February 19, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of ownership stake without immediate performance data or strategic commentary from the company itself.

Positives

• Newtyn Management, LLC and its affiliate have disclosed a significant ownership stake, indicating confidence or strategic interest in QuidelOrtho Corporation.
• The filing clearly outlines the beneficial ownership percentages for both entities, providing transparency to the market.

Risks

• The filing does not explicitly state the purpose of the increased stake, leaving room for speculation regarding potential activist intentions or future strategic moves.
• While not a direct negative, any significant shift in beneficial ownership by a substantial investor can introduce market volatility if intentions are not clearly communicated.

Future Outlook

The filing is primarily a disclosure of ownership and does not contain forward-looking statements or guidance from QuidelOrtho Corporation. The future outlook for the company will depend on its operational performance and strategic initiatives, not this ownership disclosure.

Industry Context

StockSavvy.ai notes that significant ownership filings like this Schedule 13G amendment by investment managers often signal a strategic interest in the company, potentially leading to increased scrutiny of management performance or a push for strategic changes within the healthcare diagnostics sector.

Stakeholder Impact

• Shareholders: Increased ownership by a significant investor may lead to increased market interest and potentially influence corporate strategy or governance.
• Management: May face increased scrutiny or pressure from Newtyn Management regarding company performance and strategic direction.

Next Steps

• Monitor future filings from Newtyn Management, LLC and Newtyn TE Partners, LP for any further changes in their stake.
• Observe QuidelOrtho Corporation's strategic communications and performance reports for potential responses or actions related to this increased ownership.

Key Dates

Recommendation

This filing is a disclosure of ownership and does not provide sufficient information on QuidelOrtho Corporation's performance or future prospects to warrant a buy or sell recommendation. It indicates a significant investor's interest, suggesting a 'hold' stance to observe further developments.

Keywords

QuidelOrtho Corporation, Schedule 13G, Newtyn Management, Newtyn TE Partners, Beneficial Ownership, Common Stock, SEC Filing, Investment Management